BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35729270)

  • 21. Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain.
    Bangert M; Flores-Chávez MD; Llanes-Acevedo IP; Arcones C; Chicharro C; García E; Ortega S; Nieto J; Cruz I
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006277. PubMed ID: 29494596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of ELISA with recombinant antigens in serological diagnosis of canine Leishmania infantum infection.
    Fujimori M; de Almeida ADBPF; Barrouin-Melo SM; Cortez LRPB; Duthie MS; Hiramoto RM; de Pinho FA; Reed SG; Sousa VRF; Souza NF; Soares RM; Tolezano JE; Sanchez MCA; Goto H
    Mem Inst Oswaldo Cruz; 2021; 116():e200428. PubMed ID: 33729396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of a glycerol-preserved direct agglutination antigen for long-term preservation: a comparative study of the detection of anti-Leishmania infantum antibodies in human and dog.
    Akhoundi B; Mohebali M; Edrissian GH; Eslami MB; Keshavarz H; Malekafzali H; Rokni MB
    Asian Pac J Trop Med; 2012 Feb; 5(2):117-20. PubMed ID: 22221754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The increased presence of repetitive motifs in the KDDR-plus recombinant protein, a kinesin-derived antigen from Leishmania infantum, improves the diagnostic performance of serological tests for human and canine visceral leishmaniasis.
    Siqueira WF; Viana AG; Reis Cunha JL; Rosa LM; Bueno LL; Bartholomeu DC; Cardoso MS; Fujiwara RT
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009759. PubMed ID: 34534217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.
    Costa LE; Lima MI; Chávez-Fumagalli MA; Menezes-Souza D; Martins VT; Duarte MC; Lage PS; Lopes EG; Lage DP; Ribeiro TG; Andrade PH; de Magalhães-Soares DF; Soto M; Tavares CA; Goulart LR; Coelho EA
    Clin Vaccine Immunol; 2014 Jan; 21(1):96-106. PubMed ID: 24256622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis.
    Pedras MJ; de Gouvêa Viana L; de Oliveira EJ; Rabello A
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):172-8. PubMed ID: 18160087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay.
    Scalone A; De Luna R; Oliva G; Baldi L; Satta G; Vesco G; Mignone W; Turilli C; Mondesire RR; Simpson D; Donoghue AR; Frank GR; Gradoni L
    Vet Parasitol; 2002 Apr; 104(4):275-85. PubMed ID: 11836028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Performance of ELISA test using recombinant rLiNTPDase2 from Leishmania infantum: a Phase II diagnosis of Canine Visceral Leishmaniasis.
    de Souza ACA; Castro RB; Dos Santos YL; Pavione NDRT; Agripino JM; Bahia MT; Machado-Coelho GLL; de Souza RF; de Oliveira LL; Souza CDSF; Bressan GC; Vasconcellos RS; de Almeida MR; Fietto JLR
    Acta Trop; 2020 Sep; 209():105535. PubMed ID: 32450137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.
    Ramos REM; Santos WJT; Magalhães FB; Diniz GTN; Costa CHN; de Melo Neto OP; Medeiros ZM; Reis CRS
    PLoS One; 2021; 16(5):e0251861. PubMed ID: 33999968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the direct agglutination test and the rK39 dipstick test for the sero-diagnosis of visceral leishmaniasis.
    Schallig HD; Canto-Cavalheiro M; da Silva ES
    Mem Inst Oswaldo Cruz; 2002 Oct; 97(7):1015-8. PubMed ID: 12471430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of three recombinant Leishmania infantum antigens in human and canine visceral leishmaniasis diagnosis.
    Fonseca AM; Faria AR; Rodrigues FT; Nagem RA; Magalhães RD; Cunha JL; Bartholomeu DC; de Andrade HM
    Acta Trop; 2014 Sep; 137():25-30. PubMed ID: 24801885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran.
    Mohebali M; Hajjaran H; Hamzavi Y; Mobedi I; Arshi S; Zarei Z; Akhoundi B; Naeini KM; Avizeh R; Fakhar M
    Vet Parasitol; 2005 May; 129(3-4):243-51. PubMed ID: 15845279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.
    Boarino A; Scalone A; Gradoni L; Ferroglio E; Vitale F; Zanatta R; Giuffrida MG; Rosati S
    Clin Diagn Lab Immunol; 2005 May; 12(5):647-53. PubMed ID: 15879027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey.
    Ozensoy S; Ozbel Y; Turgay N; Alkan MZ; Gul K; Gilman-Sachs A; Chang KP; Reed SG; Ozcel MA
    Am J Trop Med Hyg; 1998 Sep; 59(3):363-9. PubMed ID: 9749626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
    Machado AS; Ramos FF; Santos TTO; Costa LE; Ludolf F; Lage DP; Bandeira RS; Tavares GSV; Oliveira-da-Silva JA; Steiner BT; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Silveira JAG; Duarte MC; Machado-de-Ávila RA; Lyon S; Gonçalves DU; Caligiorne RB; Coelho EAF
    Exp Parasitol; 2020 Sep; 216():107941. PubMed ID: 32622940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.
    Fujisawa K; Silcott-Niles C; Simonson P; Lamattina D; Humeres CA; Bhattacharyya T; Mertens P; Thunissen C; O'Rourke V; Pańczuk M; Whitworth JA; Salomón OD; Miles MA
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009552. PubMed ID: 34280201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of immunodiagnostic tests to differentiate between dogs naturally infected with Leishmania infantum and Leishmune(®)-vaccinated dogs.
    Ribeiro RA; Teixeira-Neto RG; Belo VS; Ferreira EC; Schallig HD; Silva ES
    Vet Res Commun; 2015 Jun; 39(2):87-95. PubMed ID: 25874857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel exo-antigen-based ELISA for the detection of canine leishmaniasis.
    Rajasekariah GH; Cardoso L; Dogcio DA; Martin SK; Smithyman AM
    Am J Trop Med Hyg; 2008 Apr; 78(4):616-23. PubMed ID: 18385358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Direct agglutination tests in the serodiagnosis of visceral leishmaniasis in the state of Pará].
    Garcez LM; Shaw JJ; Silveira FT
    Rev Soc Bras Med Trop; 1996; 29(2):165-80. PubMed ID: 8713608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis.
    el Harith A; Chowdhury S; al-Masum A; Semião-Santos S; Karim E; el-Safi S; Haque I
    J Clin Microbiol; 1995 Aug; 33(8):1984-8. PubMed ID: 7559934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.